Investors

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.’s financial performance into perspective.

Search
(ENZN) NASDAQ
Last Trade9.81
Change(%)price0.00
Volume204576
News
  • 09-10-2009

    Enzon to Present at NewsMakers...

    Enzon to Present at NewsMakers in the Biotech Industry Conference

    click here for more information

  • 07-27-2009

    Enzon to Release Second Quarte...

    Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow

    click here for more information

  • 07-27-2009

    Enzon to Present at BMO Focus...

    Enzon to Present at BMO Focus on Healthcare Conference

    click here for more information

  • 07-23-2009

    Enzon Enhances Governance with...

    Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

    click here for more information

  • 07-27-2009

    Enzon to Release Second Quarte...

    Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow

    click here for more information

  • 04-23-2009

    Enzon's Board of Directors Rea...

    Enzon's Board of Directors Reaffirms Support of its Chairman and CEO

    click here for more information

  • 02-13-2009

    Enzon to Release Fourth Quarte...

    Enzon to Release Fourth Quarter 2008 Earnings on Thursday, February 19, 2009; Conference Call and Webcast to Follow

    click here for more information

  • 08-11-2008

    Enzon Pharmaceuticals Announce...

    Enzon Pharmaceuticals Announces Intention to Explore Strategic Alternatives for Specialty Pharmaceuticals Business
    -- Enzon Continues to Pursue Plan to Spin-off Biotechnology Business --

    click here for more information

  • 05-06-2009

    Enzon Reaches Phase II Dose fo...

    Enzon Reaches Phase II Dose for PEG-SN38
    -- Composition of matter patent granted until 2027--

    click here for more information

  • 03-19-2009

    Enzon Reveals New LNA Targets<...

    Enzon Reveals New LNA Targets
    -- Data will be presented at upcoming American Association for Cancer Research Meeting--

    click here for more information

  • 01-28-2009

    Enzon Nominates Two New Candid...

    Enzon Nominates Two New Candidates for its Board of Directors

    click here for more information

  • 12-01-2008

    Enzon Discontinues its Plan to...

    Enzon Discontinues its Plan to Spin-off its Biotechnology Business

    click here for more information